About Prof. Robert Batey, PhD

Co-Founder, Chief Scientific Officer

Education

  • PhD, Organic Chemistry, Imperial College of Science, Technology and Medicine, London, UK
  • BA, Chemistry, University of Oxford, UK

Special Interests

  • Organic synthesis
  • Medicinal chemistry and chemical biology

Rob is a co-founder of Proteorex and leads the scientific and research work on the team. His research expertise lies in the areas of organic synthesis, medicinal chemistry and chemical biology.

Rob is also a Full Professor and the Chair of the Department of Chemistry at the University of Toronto. He is also the Chair of the 100th Canadian Society of Chemistry Conference that will be held in Toronto in 2017. Since joining the Faculty of the University of Toronto in 1994 he has been the recipient of several awards including the Canadian Society of Chemistry – Bader Award (2014), Faculty of Arts and Science Outstanding Teaching Award (2012-13), Merck-Frosst Centre for Therapeutic Research Award (2006), Merck Academic Development Program Award (2005), Premier’s Research Excellence Award (2000), the Bio-Méga/Boehringer Ingelheim Young Investigator Award for Organic Chemistry (1998) and the Canadian Society of Chemistry / Astra Pharma Award (1997). Rob has over 100 peer-reviewed publications in the areas of organic synthesis, total synthesis, medicinal chemistry, heterocyclic synthesis, organoboron and pericyclic reactions, peptides and depsipeptides, alkaloids, antibiotics and oncology.

Rob obtained a BA in chemistry from the University of Oxford and a PhD in organic chemistry from the Imperial College London. Upon completion of his PhD, Rob undertook post-doctoral fellowships in synthetic organic chemistry at the University of Pennsylvania, and in medicinal chemistry at the Upjohn Company.